Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rapid Therapeutic Science Laboratories has a quick ratio of 0.03. It indicates that the company cannot currently fully pay back its current liabilities.
RTSL's Quick Ratio is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.19 * Ranked among companies with meaningful Quick Ratio only.
Rapid Therapeutic Science Laboratories (OTCPK:RTSL) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Rapid Therapeutic Science Laboratories Quick Ratio Related Terms
Rapid Therapeutic Science Laboratories Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapid Therapeutic Science Laboratories Quick Ratio Chart
Rapid Therapeutic Science Laboratories Annual Data
For the Shell Companies subindustry, Rapid Therapeutic Science Laboratories's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rapid Therapeutic Science Laboratories Quick Ratio vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Rapid Therapeutic Science Laboratories's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Rapid Therapeutic Science Laboratories's Quick Ratio falls into.
Rapid Therapeutic Science Laboratories Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapid Therapeutic Science Laboratories (RTSL) has a Quick Ratio of 0.03 as of Jun. 2023. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Rapid Therapeutic Science Laboratories and its competitors.
Is Rapid Therapeutic Science Laboratories' Quick Ratio too high?
Rapid Therapeutic Science Laboratories' current Quick Ratio is 0.03. The Diversified Financial Services industry median Quick Ratio is 3.19. Rapid Therapeutic Science Laboratories' value of 0.03 is 99.1% below this industry median.
How does Rapid Therapeutic Science Laboratories' Quick Ratio compare to VRAYQ and NNMX?
Rapid Therapeutic Science Laboratories' Quick Ratio of 0.03 can be compared against companies in the Diversified Financial Services industry. The industry median Quick Ratio is 3.19. Rapid Therapeutic Science Laboratories' value of 0.03 is 99.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Diversified Financial Services company?
The median Quick Ratio among Diversified Financial Services companies is 3.19, based on 492 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rapid Therapeutic Science Laboratories's current Quick Ratio of 0.03 is 99.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Rapid Therapeutic Science Laboratories and its competitors. For the Diversified Financial Services industry, the median Quick Ratio is 3.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rapid Therapeutic Science Laboratories's current Quick Ratio is 0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Therapeutic Science Laboratories stock overvalued right now?
Rapid Therapeutic Science Laboratories (RTSL) has a current Quick Ratio of 0.03. The current Quick Ratio is 0.03 and 99.1% below the Diversified Financial Services industry median of 3.19. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Rapid Therapeutic Science Laboratories (RTSL), the current Quick Ratio is 0.03 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rapid Therapeutic Science Laboratories Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RTSL has been successfully added to your 
